Publication Beamlines Strategic Pillar
(2022). ANTIBODY EPITOPE. Patent Number: PT3311171T.
(2023). Novel tnf structure for use in therapy. Patent Number: PT3311168T.
(2020). ANTI-BCMA ANTIBODIES, BIESPECIFIC ANTIGEN BINDING MOLECULES THAT BIND BCMA AND CD3, AND THEIR USES. Patent Number: PT3337824T.
(2025). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: IL298041B2.